Company intelligence / Profile preview

Grupo Fleury

São Paulo, São Paulo, Brazilgrupofleury.com.br ↗

Ownership: Private
Employees: ~22400
Development stage: Commercial

Overview

Grupo Fleury is Brazil’s leading provider of diagnostic medicine with over 245 million exams performed annually across more than 39 brands. The company has expanded into precision medicine—including genomics—and digital health platforms. It partners internationally to bring advanced diagnostics to Brazil and continues to innovate in patient care coordination through its digital platform. No clinical trial results are reported since it does not develop therapeutics.

Therapeutic areas: OncologyOtherRheumatologyNeurologyWomen's Health
Modalities: Imaging (Ultrasound, MRI, CT)Laboratory tests (blood tests and genetic testing)Precision medicine diagnostics
Industry: Medical Imaging

Partnerships

C₂N Diagnostics – partnership for blood-based Alzheimer’s disease biomarker testing in Brazil

Beyond the preview

Go deeper on Grupo Fleury.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grupo Fleury.

Explore the full profile